1. A multi-center, open-label, randomized phase III trial of first-line chemotherapy with capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer. Issue 3 (May 2017) Authors: Hwang, In Gyu; Ji, Jun Ho; Kang, Jung Hun; Lee, Hyo Rak; Lee, Hui-Young; Chi, Kyong-Choun; Park, Suk Won; Lee, Su Jin; Kim, Seung Tae; Lee, Jeeyun; Park, Se Hoon; Park, Joon Oh; Park, Young Suk; Lim, Ho Yeong; Kang, Won Ki Journal: Journal of geriatric oncology Issue: Volume 8:Issue 3(2017) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Attenuated FOLFIRINOX in the salvage treatment of gemcitabine‐refractory advanced pancreatic cancer: a phase II study. Issue 1 (4th June 2018) Authors: Kim, Jung Hoon; Lee, Sang‐Cheol; Oh, Sung Yong; Song, Seo‐Young; Lee, Namsu; Nam, Eun Mi; Lee, Soonil; Hwang, In Gyu; Lee, Hyo Rak; Lee, Kyu Taek; Bae, Sang‐Byung; Kim, Han Jo; Jang, Joung Soon; Lim, Do Hyoung; Lee, Hyun Woo; Kang, Seok Yun; Kang, Jung Hun Journal: Cancer communications Issue: Volume 38:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗